The product is the first device manufactured by a device reprocessor, and, according to the company, it is best utilized as part of a reprocessing program. Reprocessing costs less than purchasing new sleeves for each patient and is more environmentally friendly. Additionally, hospitals may be able to reduce their costs for DVT sleeves through a single contract for both the device and third-party reprocessing, according to the company.
“Restep marks the first time we can tangibly demonstrate what the integration of reprocessing into the OEM business model means for the industry. By creating a medical device solution that integrates original manufactured and reprocessed devices, we have introduced a new precedent in how technology suppliers can offer value to hospitals,” said Lars Thording, Stryker Sustainability Solutions’ senior director of marketing and public affairs, in a statement. “Value lies in true sustainability — environmental and financial sustainability. With Restep, hospitals will be able to opt for less environmentally impactful products without sacrificing quality or financial prudence.”
More Articles Featuring Stryker Sustainability Solutions:
Reprocessing for the Future: 10 Best Practices for a Hospital Reprocessing Program
